Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
GILD AMGN BIIB CELG Market Drivers Consumer Small Growth Munis 
United States  USA  |  Investing Themes


Processing
Collecting data for ENMD

EntreMed quote and profile

 
 Companies |  Insiders  | Dashboard  
     
1.85
  
STOCK
(0.02)  Macroaxis: -1.07 Down   1.07%  
Year To Date
1.233.73
Trading Day 
1.81.91
May 18 2013 

Diversification Suggestion

Use EntreMed to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly
Analyze EntreMed Inc Trend or Check current 30 days EntreMed correlation with market (S&P 500)
1 Month Beta 1.06  
Highest Price:  
Lowest Price:  
1.99  
1.79  
April 19 2013 
April 29 2013 
EntreMed returns are very sensitive to returns on the market. As market goes up or down, EntreMed is expected to follow.
EntreMed Inc llmost one BetaEntreMed Inc Beta Legend
ENMD United States Nasdaq
EntreMed Inc
Healthcare
Biotechnology
http://www.entremed.com
Contact Number: 240. 864. 2600
Currency: USD - US Dollar
Traded on Nasdaq Capital Markets
    
Current Valuation45.29 M
Shares Outstanding27.02 M
Number of Shares Shorted240.41 K
Revenue669.31 K
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
 United States Nasdaq   0.69 % Macroaxis: 0.69 Moved Up  
 
 thisRed ENMD ENMD agains markets  1.07 % Macroaxis: change 1.07 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

EntreMed Leadership

Ken Ren Interim CEO, Ph.D
Ken MD CEO
Dwight Bush Independent Vice Chairman of the Board
Wei-Wu He Executive Chairman, MBA

EntreMed Price and Market Media

The median price of EntreMed for the period between Thu, Apr 18, 2013 and Sat, May 18, 2013 is 1.85 with a coefficient of variation of 2.49. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 1.85, and mean deviation of 0.03. The Stock received some media coverage during the period.
EntreMed         Market
Price Growth (%)
 
1
Entremed reports patent issuance for its lead drug candidate...05/08/2013Macroaxis: News
2
EntreMed Announces Quarterly Earnings05/16/2013Macroaxis: News

EntreMed Summary

EntreMed Inc [ENMD] is traded on Nasdaq Capital Markets in USA. It is located in Rockville, MD and employs 8 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 48.37 M. EntreMed Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 27.02 M outstanding shares of which 240.41 K shares are currently shorted by private and institutional investors with about 3.6 trading days to cover.
EntreMed, Inc., a clinicalstage pharmaceutical company, engages in developing therapeutics to treat cancer and other diseases primarily in the United States and China. more
Past Market
Over 30
Days
1
Out Of
100
 
Chance of
More
Than
97 %
 
Follow EntreMed with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add EntreMed to your reader
 

EntreMed Research Report

EntreMed vs. Gilead

Correlation analysis and fundamentals comparison between EntreMed Inc and Gilead Sciences

EntreMed Executives

Hu JD COO, General Counsel and Secretary
Wong Hu COO, General Counsel, Secretary

EntreMed Directors

Ginny Dunn Associate Director of Corporate Communications and Investor Relations
Tak Mak Director
Mark Randall Independent Director
James Huang Independent Director, MBA
Y Wu Independent Director, MBA

EntreMed Fundamentals

Total Asset vs Current Liabilities
Net Income vs Number of Employees
Total Asset vs Return On Asset
Cash per Share vs Number of Employees

EntreMed vs Competition

EntreMed vs. Gilead Sciences Inc
EntreMed vs. Amgen Inc
EntreMed vs. Biogen Idec Inc
EntreMed vs. Celgene Corporation
EntreMed vs. Regeneron Pharmaceuticals Inc
EntreMed vs. Alexion Pharmaceuticals Inc
EntreMed vs. Vertex Pharmaceuticals Incorporated
EntreMed vs. Illumina Inc
EntreMed vs. BioMarin Pharmaceutical Inc
EntreMed vs. Onyx Pharmaceuticals Inc

EntreMed May 18 2013 Opportunity Range

Downside Deviation3.26
Information Ratio(0.08)
Maximum Drawdown15.28
Value At Risk(3.24)
Potential Upside4.4

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium